Netflix Stock Price Soars After Earnings Report Record New Memberships
Netflix stock price ( NASDAQ: NFLX ) is up more than 13% in the after-hours following its release of the fourth-quarter earnings report for fiscal year 2024. The streaming company recorded a 16% increase in revenue year-over-year, reaching 19% on a foreign exchange (F/X) neutral basis, which the
If you invested $1000 in Chipotle Mexican Grill (NYSE:CMG) 5 years ago, here's how much it's worth today
They say, “If it looks like a restaurant, cooks food like a restaurant, and serves food like a restaurant, then it’s probably a restaurant.”. However, this might not be how investors see Chipotle Mexican Grill ( NYSE:CMG ). Chipotle’s stock is currently trading at a P/E ratio of around 54, while many
Iconic Brand Group Launches Tampa-Based Business Consulting Firm and Marketing Agency Built by Proven Operators
Newsfile
7 minutes ago
Tampa, Florida--(Newsfile Corp. - April 3, 2026) - Iconic Brand Group, a Tampa, Florida-based business consulting firm and full-service marketing agency, today officially announced its launch, introducing a new model designed to help companies scale
First Bank Announces First Quarter 2026 Earnings Conference Call
GlobeNewswire Inc.
16 minutes ago
HAMILTON, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- First Bank (Nasdaq Global Market: FRBA) invites participation in a conference call to discuss the Company’s financial and operating performance during its first quarter ending on March 31, 2026. Even
RJM Design Group Selected to Lead Design of Ontario Sports Empire, Western United States' Largest Multi-Sport Complex
Newsfile
45 minutes ago
Ontario, California--(Newsfile Corp. - April 3, 2026) - RJM Design Group has been selected to lead landscape architecture, master planning, and site design for the Ontario Sports Empire (OSE), a large-scale multi-sport complex in Ontario, California.
Skygen.AI Launches Autonomous Computer Use Agent: A New Chapter in Corporate Efficiency
Newsfile
50 minutes ago
New York, New York--(Newsfile Corp. - April 3, 2026) - As the race for AI-driven productivity intensifies, Skygen.AI has officially released its autonomous execution agent, signaling a major shift in how enterprises approach digital labor. The launch
Navient to announce first quarter 2026 results, host earnings webcast April 29
GlobeNewswire Inc.
2 hours ago
HERNDON, Va., April 03, 2026 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI) will host an audio webcast to review its first quarter 2026 results on Wednesday, April 29, 2026, at 8:00 a.m. Eastern Time. The webcast will be available on Navient.com/investor
HII Redelivers USS New Jersey (SSN 796) from Post-Shakedown Availability at Newport News Shipbuilding
GlobeNewswire Inc.
2 hours ago
NEWPORT NEWS, Va., April 03, 2026 (GLOBE NEWSWIRE) -- HII’s (NYSE: HII) Newport News Shipbuilding division has completed post-shakedown availability (PSA) work on Virginia-class fast attack submarine USS New Jersey (SSN 796). The submarine was redeli
INTCO Medical Expands Non-Latex Glove Portfolio to Meet Growing Global Demand for Synthetic Materials
Newsfile
2 hours ago
Shanghai, China--(Newsfile Corp. - April 3, 2026) - INTCO Medical has announced the expansion of its non-latex glove portfolio with the launch of two new product lines-Syntex™ Synthetic Latex Gloves and Synmax Pro Gloves-aimed at addressing evolving
Rhythm Pharmaceuticals Announces Changes to Board of Directors
GlobeNewswire Inc.
2 hours ago
-- Kim Popovits appointed as new Director; Ed Mathers to depart -- BOSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patien
MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
3 hours ago
CARMEL, Ind., April 03, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of end
MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026
GlobeNewswire Inc.
4 hours ago
Study will highlight novel iNKT cell-based combinations in checkpoint-refractory diseaseData expected to inform immune modulation, treatment sequencing strategy, and clinical durability of response NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- MiNK Th
